Orthofix International (OFIX) Misses Q1 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- CoreWeave stock drops on dilution fears and debt concerns
Orthofix Reports First Quarter 2022 Results
May 6, 2022 7:00 AM EDTNet sales of $106.4 million, an increase of 1% on a reported basis and 2% on a constant currency basis over prior year New product sales drive solid growth in Biologics, Spinal Implants, and Orthopedics FDA grants PMA for AccelStim bone growth stimulator LIPUS technology expands our indications into fresh fracture care FDA clearance received for the TrueLok EVO Ring Fixation system, which enables clear radiographic visualization Reaffirming 2022 guidance
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today reported... More



